Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kate Loranger
Observed names:
K Loranger,
K. Loranger
Observed institutions:
Rush University Medical Center,
San Francisco General Hospital,
Grady Memorial Hospital,
Emory University,
University of California, San Francisco,
John H. Stroger, Jr. Hospital of Cook County,
Natera (United States),
UCSF Helen Diller Family Comprehensive Cancer Center
show all 8
OpenAlex ID:
A5081207162
Selective Versus Universal Screening for Lynch Syndrome: A Six-Year Clinical Experience
2014
·
Trilokesh D. Kidambi
, Amie Blanco
, et al.
·
Digestive Diseases and Sciences
·
29
A genotype-first approach identifies high incidence of NF1 pathogenic variants with distinct disease associations
2025
·
Anton Safonov
, Tomoki T. Nomakuchi
, et al.
·
Nature Communications
·
23
Characteristics of individuals with breast cancer rearrangements in BRCA1 and BRCA2
2014
·
Sarah A. Jackson
, Andrew A. Davis
, et al.
·
Cancer
·
18
PDF
Tumor-informed assessment of molecular residual disease and its incorporation into practice for patients with early and advanced-stage colorectal cancer (CRC-MRD Consortia).
2020
·
Pashtoon Murtaza Kasi
, Farshid Dayyani
, et al.
·
Journal of Clinical Oncology
·
11
Refining the interpretation of variants of uncertain significance in hereditary cancer screening through integrated RNA sequencing
2024
·
Youbao Sha
, J. Bryce Ortiz
, et al.
·
Genetics in Medicine Open
·
5
SO-34 Clinical experience of a personalized and tumor-informed circulating tumor DNA assay for minimal residual disease detection in oligometastatic colorectal cancer patients
2020
·
S. Cohen
, N. Hook
, et al.
·
Annals of Oncology
·
4
PDF
P591: Examining likely-somatic variants in cancer susceptibility genes identified through germline multigene panel testing
2024
·
Kate Loranger
, Jingwen Zhang
, et al.
·
Genetics in Medicine Open
·
1
PDF
Abstract A39: The consortium of underserved BRCA testers: A multisite collaboration to study underserved families at risk of hereditary breast and ovarian cancer
2011
·
Mary S. Beattie
, Christina Seelaus
, et al.
·
Cancer Epidemiology Biomarkers & Prevention
·
1
Diagnostic yield and characteristics of germline-positive genetic testing ordered by obstetricians and gynecologists in female patients with a personal history of cancer
2024
·
Sarah Lee
, Mia Mackall
, et al.
·
Gynecologic Oncology
P526: Integration of RNA sequencing improves hereditary cancer genetic testing*
2023
·
Youbao Sha
, J. Bryce Ortiz
, et al.
·
Genetics in Medicine Open
PDF
P555: Initial experience from a single laboratory on custom hereditary cancer panel orders
2023
·
Kate Loranger
, Katherine Howard
, et al.
·
Genetics in Medicine Open
PDF
eP302: Examining a hereditary cancer STAT panel and the importance of automatic reflex testing
2022
·
Laura Westbrook
, Melissa Maisenbacher
, et al.
·
Genetics in Medicine
81MO Clinical experience of a personalized and tumour-informed circulating tumour DNA assay for minimal residual disease detection in oligometastatic colorectal cancer patients
2020
·
S.A. Cohen
, N. Hook
, et al.
·
Annals of Oncology
PDF
Tu1897 Lynch Syndrome Screening Strategies: A Six Year Clinical Experience
2014
·
Trilokesh Kidambi
, Amie Blanco
, et al.
·
Gastroenterology
P2-13-03: Comparative Assessment of 636 Women at Risk for Hereditary Breast Cancer within 3 Public Hospitals: The Consortium of Underserved BRCA Testers.
2011
·
MS Beattie
, P Ganschow
, et al.
·
Cancer Research
Show more works
View as search
Works count:
15
Citation count:
91
H-index:
4
I10-index:
4
Year
Topic
Type
